| Description | Debrisoquine is an antihypertensive drug similar to guanethidine. |
| Synonyms | Tendor, Isocaramidine, Debrisochinum, Debrisoquine, Debrisoquin, Debrisoquina |
| molecular weight | 273.31 |
| Molecular formula | C10H15N3O4S |
| CAS | 581-88-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| References | 1. Laine K, Tybring G, Härtter S, Andersson K, Svensson JO, Widén J, Bertilsson L. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clin Pharmacol Ther. 2001 Oct;70(4):327-35. PubMed PMID: 11673748. 2. Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin. Clin Pharmacol Ther. 1996 Nov;60(5):512-21. PubMed PMID: 8941024. 3. Lautenschlager MT, Viktor S, Müller UA, Hoffmann A. [Comparison of serum concentrations of caffeine, 4-methylaminoantipyrine, sulfamethazine and debrisoquin following oral administration of these substances as a cocktail in type II diabetics before and after insulin therapy]. Pharmazie. 1996 Oct;51(10):750-3. German. PubMed PMID: 8999440. 4. Marandi T, Dahl ML, Kiivet RA, Rägo L, Sjöqvist F. Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population. Pharmacol Toxicol. 1996 May;78(5):303-7. PubMed PMID: 8737964. |